1. [Beneficial effects of diltiazem in exertion stable angina. Evaluation of coronary hemodynamics during cardiac pacing].
- Author
-
Vigorito C, Giordano A, De Caprio L, Vitale D, Ferrara N, Canonico V, Silvestri P, Casaburi E, Ferraro P, and Rengo F
- Subjects
- Aged, Angina Pectoris drug therapy, Angina Pectoris etiology, Blood Pressure, Diltiazem administration & dosage, Female, Humans, Injections, Intravenous, Male, Middle Aged, Angina Pectoris physiopathology, Cardiac Pacing, Artificial adverse effects, Diltiazem therapeutic use
- Abstract
We evaluated the protective effect of Diltiazem from pacing-induced myocardial ischemia in 9 patients (pts) with coronary heart disease (CAD) and stable effort angina by studying the changes in systemic and coronary hemodynamics during pacing. Hemodynamic parameters were evaluated at baseline and at peak pacing before and after Diltiazem, 25 mg i.v. Diltiazem prevented angina in 6 of 7 pts who presented angina in the control pacing. This beneficial effect was accompanied at peak pacing rate by a significant fall in ST depression, arterial pressure, rate-pressure product and left ventricular (LV) end-diastolic pressure, while no significant changes were observed in LV dp/dt max, coronary blood flow and coronary vascular resistance. Therefore, Diltiazem exerts a protective effect from pacing-induced myocardial ischemia in pts with CAD and stable effort angina, without impairing LV function. This beneficial effect is due to a reduction in myocardial metabolic requirements, rather than to an improvement of blood supply to the ischemic myocardium.
- Published
- 1986